For a researcher tracking this drug, waiting for the remaining TRIUMPH readouts and the FDA review cycle is a defensible position
[DOI] [PMC free article] [PubMed] [Google Scholar] 113.Grossman D.C., Bibbins-Domingo K., Curry S.J., Barry M.J., Davidson K.W., Doubeni C.A., Epling J.W., Jr., Kemper A.R., Krist A.H., Kurth A.E., et al
"So, for semaglutide, there's some preclinical evidence showing that this medication has neuro-protective effects and is also anti-inflammation, which can address a lot of risk factors associated with Alzheimer's disease." This means GLP-1 medications may not only lower blood sugar to reduce the risk for Alzheimer's disease, but they may also play a role in reducing neuro-inflammation
By tailoring the plan, doctors help people achieve safe and lasting weight loss, making sure any health issues, like diabetes, are managed well
2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association
The compounded semaglutide was produced before May 22, 2025, and is still within its expiration date: Larger 503B outsourcing pharmacies had until May 22, 2025 to stop making new batches of compounded semaglutide
